Clinical-demographic and adverse-event characterization during treatment with Heberprot-P
Introduction: Heberprot-P is a novel drug that has come for the reduction of amputation risks; like any drug it is not devoid of adverse events. Objectives: to characterize patients during Heberprot-P treatment according to demographic and clinical variables, as well as to describe adverse events re...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
Editorial Ciencias Médicas
2020-10-01
|
| Series: | Acta Médica del Centro |
| Subjects: | |
| Online Access: | http://www.revactamedicacentro.sld.cu/index.php/amc/article/view/1254 |